Showing 311-320 of 2293 results for "".
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31065/Recent studies highlighted in Practical Neurology’s January 2008 issue provide significant insights into neurological conditions and their broader health implications. Notably, research published in Neurology reveals that patients with Restless Legs Syndrome (RLS) face double the risk of stroke and
Spinal Muscular Atrophy
https://practicalneurology.com/diseases-diagnoses/neuromuscular/spinal-muscular-atrophy-1/31692/A review of available treatments.Epilepsy Essentials
Infantile Spasms: The Biggest Little Seizureshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-infantile-spasms-the-biggest-little-seizures/31995/Prompt, effective treatment of infantile epileptic spasms syndrome can prevent intellectual disability and lifelong medically refractory epilepsy in some infants.The Whole Physician: Addressing Imposter Phenomenon in the Physician Population
https://practicalneurology.com/diseases-diagnoses/imaging-testing/the-whole-physicianbraddressing-imposter-phenomenon-in-the-physician-population/32117/Physicians and medical institutions need to take steps to recognize and combat imposter phenomenon, also known as imposter syndrome.Postural Orthostatic Tachycardia Syndrome
https://practicalneurology.com/diseases-diagnoses/imaging-testing/postural-orthostatic-tachycardia-syndrome/31643/POTS is a cause of dizziness, fatigue, cognitive dysfunction, and headaches that can significantly contribute to poor quality of life.Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis: Current Landscape and Potential Utility in Clinical Practice
https://practicalneurology.com/diseases-diagnoses/neuromuscular/blood-and-cerebrospinal-fluid-biomarkers-in-amyotrophic-lateral-sclerosis-current-landscape-and-potential-utility-in-clinical-practice/35542/Amyotrophic lateral sclerosis biomarkers are increasingly shaping the development of new treatments.Identification, Management, and Prevention of Polypharmacy in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/identification-management-and-prevention-of-polypharmacy-in-multiple-sclerosis/32088/Rational prescription practices in multiple sclerosis treatment are key to the prevention and mitigation of polypharmacy.Multiple Sclerosis in the Black Population of the United States
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-the-black-population-of-the-united-states/31756/Black people with multiple sclerosis are affected by frequent relapses, early disability accrual, and rapid disease progression.Sphingosine-1-Phosphate Modulators for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/sphingosine-1-phosphate-modulators-for-multiple-sclerosis/31629/Sphingosine-1-phosphate modulators may act through more than just inhibition of neuroimmune and neuroinflammatory effects of multiple sclerosis.- Building a better UPDRShttps://practicalneurology.com/columns/practice-management/building-a-better-updrs/31010/Since the late 1980s, the Unified Parkinson’s Disease Rating Scale (UPDRS) has been a cornerstone in assessing Parkinson’s Disease (PD), primarily focusing on motor symptoms such as finger tapping, fist opening, and rising from a chair. However, over the past two decades, advancements in PD research